Search Results - "Eisenbach, L"
-
1
Nanotechnology-based immunotherapeutic approach for tumour eradication
Published in European journal of cancer (1990) (01-07-2016)Get full text
Journal Article -
2
O‐glycosylated versus non‐glycosylated MUC1‐derived peptides as potential targets for cytotoxic immunotherapy of carcinoma
Published in Clinical and experimental immunology (01-01-2006)“…Summary Due to the fact that many cellular proteins are extensively glycosylated, processing and presentation mechanisms are expected to produce a pool of…”
Get full text
Journal Article -
3
Mycobacterium leprae specific genomic target in the promoter region of probable 4-alpha-glucanotransferase ( ML1545 ) gene with potential sensitivity for polymerase chain reaction based diagnosis of leprosy
Published in International journal of mycobacteriology (01-06-2016)“…Abstract With the absence of an effective diagnostic tool for leprosy, cases with negative bacteriological index and limited clinical manifestations often pose…”
Get full text
Journal Article -
4
Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines
Published in British journal of cancer (21-07-2003)“…Despite advances in the management of solid tumours, the development of metastases continues to be the most significant problem and cause of death for cancer…”
Get full text
Journal Article -
5
Antimetastatic vaccination of tumor-bearing mice with two types of IFN- gamma gene-inserted tumor cells
Published in The Journal of immunology (1950) (15-02-1993)“…IFN-gamma genes were introduced through retroviral vectors into the high metastatic, low H-2Kb class I expressor, and poorly immunogenic 3LL-D122 clone. Two…”
Get full text
Journal Article -
6
MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides
Published in British journal of cancer (19-07-2004)“…Bladder carcinoma is the fourth most common cancer in men and the eighth most common cancer among women. Our study is aimed to characterise tumour-associated…”
Get full text
Journal Article -
7
Developmental expression of the alpha receptor for platelet-derived growth factor, which is deleted in the embryonic lethal Patch mutation
Published in Development (Cambridge) (01-05-1992)“…The alpha receptor of PDGF (Pdgfra) is expressed in primitive endoderm and mesoderm derivatives throughout embryogenesis. In the early primitive streak stage…”
Get full text
Journal Article -
8
'1-8 interferon inducible gene family' : putative colon carcinoma-associated antigens
Published in British journal of cancer (17-12-2007)Get full text
Journal Article -
9
918 - Nanotechnology-based immunotherapeutic approach for tumour eradication
Published in European journal of cancer (1990) (01-07-2016)Get full text
Journal Article -
10
Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas
Published in The Journal of immunology (1950) (15-12-1997)“…CTLs recognize antigenic peptides bound to MHC class I Ags on the cell surface of tumor cells. Tumor-associated Ag (TAA) peptides are 8 to 10 amino acids long…”
Get full text
Journal Article -
11
Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma : growth inhibition and differentiation of B16-F10.9 tumor cells
Published in Oncogene (31-07-1997)“…Interleukin-6 (IL-6) inhibits the growth of melanocytes and of early stage melanoma cells, but not that of advanced melanoma cells. The in vitro IL-6 response…”
Get full text
Journal Article -
12
Letters: Certification program overlooked
Published in Environmental science & technology (01-08-1997)Get full text
Journal Article -
13
c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression
Published in Oncogene (01-04-1994)“…Reduced co-expression of the c-fos and c-jun protooncogenes has been correlated with the down regulation of H-2K class I major histocompatibility antigens in…”
Get more information
Journal Article -
14
Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells
Published in Gene therapy (01-12-1995)“…Metastatic clones of some tumors manifest an impaired expression of class I major histocompatibility complex (MHC) antigens. High metastatic, low immunogenic…”
Get more information
Journal Article -
15
Reversal of the Metastatic Phenotype in Lewis Lung Carcinoma Cells after Transfection with Syngeneic H-2Kb Gene
Published in Proceedings of the National Academy of Sciences - PNAS (01-06-1988)“…High metastatic clones of the murine 3LL carcinoma express greatly reduced levels of H-2Kb major histocompatibility complex class I antigens, while low…”
Get full text
Journal Article -
16
Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing
Published in Journal of immunotherapy (1997) (01-11-2000)“…The development of a cell-free synthetic vaccine to induce an effective cytotoxic T lymphocyte response is an important challenge in T-cell--mediated immunity…”
Get full text
Journal Article -
17
A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice
Published in The Journal of biological chemistry (06-06-2003)“…The high toxicity of most chemotherapeutic drugs and their inactivation by multidrug resistance phenotypes motivated extensive search for drugs with new modes…”
Get full text
Journal Article -
18
Immunotherapy of tumor metastasis via gene therapy
Published in Natural immunity (01-03-1994)“…Active cellular immunotherapy of cancer, via gene-modified tumor cells, may develop to an effective treatment modality. Here we discuss some of the cytokines…”
Get more information
Journal Article -
19
c-fos transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence
Published in International journal of cancer (15-06-1990)“…Transfection with c-fos genes of cells of a highly metastatic (H-2K- H-2D+) clone, DI22, of the 3LL carcinoma, causes activation of H-2K gene expression…”
Get more information
Journal Article -
20
The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes
Published in Oncogene (01-02-1988)“…The c-fos proto-oncogene and H-2K class I major histocompatibility antigens are differentially expressed in low-metastatic Lewis lung carcinoma clones, but not…”
Get more information
Journal Article